We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Eureka Therapeutics

News List

Eureka Therapeutics’ nasal spray protects against Covid-19 in studies pharmaceutical-technology
December 16, 2020
Eureka Therapeutics has announced that preclinical results of its InvisiMask Human Antibody Nasal Spray in mice showed it offers up to ten hours protection against SARS-CoV-2 S pseudotyped virus infection.
Eureka Therapeutics Announces Data Presentations Validating Its Proprietary E-ALPHA Discovery Platform at the 2018 ASH Annual Meeting firstwordpharma
December 02, 2018
Eureka Therapeutics, Inc., a clinical stage biopharmaceutical company with the goal of curing cancer by developing novel T-cell therapies that harness the evolutionary power of the immune system, announced today that five abstracts, including four oral pr